CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,777,199 | $12,015,223 | $11,654,606 | $9,283,642 |
| Short-Term Investments | $1,473,112 | $1,077,054 | $4,830,335 | $1,443,413 |
| Receivables | $9,938,393 | $10,835,378 | $7,623,543 | $7,129,079 |
| Inventory | $3,130,014 | $3,138,664 | $2,554,861 | $2,480,369 |
| Other Curr. Assets | $362,346 | $10,362,939 | -$2,706,185 | $0 |
| Total Curr. Assets | $21,888,144 | $26,744,945 | $23,957,160 | $20,336,503 |
| Property Plant & Equip (Net) | $13,079,000 | $11,642,892 | $11,773,489 | $11,699,213 |
| Goodwill | $234,904 | $234,904 | $231,586 | $183,469 |
| Intangibles | $2,609,506 | $2,198,549 | $2,112,744 | $755,779 |
| Long-Term Investments | $4,797,901 | $4,641,243 | $3,729,643 | $4,416,534 |
| Tax Assets | $250,297 | $0 | $113,026 | $52,600 |
| Other NC Assets | $1,529,239 | $819,637 | $53,440 | $513,636 |
| Total NC Assets | $22,500,847 | $19,537,225 | $17,812,614 | $17,621,231 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $44,388,991 | $46,282,170 | $41,769,774 | $42,498,176 |
| Liabilities | – | – | – | – |
| Payables | $2,613,000 | $2,841,739 | $2,010,065 | $1,622,617 |
| Short-Term Debt | $392,204 | $450,216 | $173,703 | $0 |
| Tax Payable | $334,231 | $417,776 | $257,913 | $318,944 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $945,857 | $494,903 | $1,467,582 | $1,740,567 |
| Total Curr. Liab. | $9,634,027 | $10,182,573 | $10,138,074 | $8,839,370 |
| LT Debt | $0 | $0 | $28,950 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $424,731 | $574,843 | $611,993 | $381,484 |
| Other NC Liab. | $407,808 | $56,962 | $270,917 | $250,198 |
| Total NC Liab. | $888,674 | $738,863 | $1,169,899 | $687,302 |
| Other Liabilities | $0 | $342,722 | $0 | $0 |
| Cap. Leases | $115,126 | $256,685 | $254,394 | $68,038 |
| Total Liabilities | $10,522,701 | $12,392,097 | $11,462,089 | $9,708,398 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1,410,661 | $0 | $0 |
| Common Stock | $11,032,752 | $10,899,412 | $10,745,447 | $13,332,876 |
| Retained Earnings | $23,344,080 | $24,034,860 | $20,837,332 | $21,125,822 |
| AOCI | $0 | -$1,410,661 | -$1,729,287 | -$2,565,384 |
| Other Equity | -$2,088,941 | -$1,805,376 | -$204,372 | -$65,906 |
| Total Equity | $32,264,695 | $33,203,208 | $29,770,965 | $31,788,603 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,601,595 | $1,996,530 | $1,423,938 | $1,029,450 |
| Total Liab. & Tot. Equity | $44,388,991 | $50,916,647 | $47,272,277 | $42,498,176 |
| Net Debt | -$6,384,995 | -$11,565,007 | -$11,451,953 | -$9,283,642 |